Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Filling the gap in Canadian evidence on the burden of PROC on QoL is essential. It will help better understand the impact of PROC on multiple aspects of the lives of patients and their caregivers and the real-life hurdles faced by PROC patients and their caregivers. The outputs of this study will help better understand the hurdles and challenges they face and the significant unmet medical need.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with PROC part of Ovarian Cancer Canada mailing lists |
| ||
| Caregiver of PROC patients part of Ovarian Cancer Canada mailing lists |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No intervention | Other | No specific intervention is assess in this study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| To estimate the quality of life of patient with ovarian cancer | Using the the Functional Assessment of Cancer Therapy - Ovarian (FACT-O) and EuroQol 5-dimendion 5-level (EQ-5D-5L) | At recruitment |
| Measure | Description | Time Frame |
|---|---|---|
| Patient's symptoms assessment | Using the Measure of Ovarian Symptoms and Treatment (MOST-T24 (V2)) | At recruitment |
| Caregiver's Quality of Life | Using the CareGiver Oncology Quality of Life (CarGOQoL) questionnaire |
Not provided
Patient Inclusion Criteria
Patients Exclusion Criteria
Patients with PSOC, defined as those who:
Patients with platinum-refractory ovarian cancer, defined as not responding or disease progressing during therapy or within three months after the last dose
Caregivers Inclusion Criteria:
Caregivers Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with ovarian cancer and caregivers of patients with ovarian cancer who are part Ovarian Cancer Canada mailing list.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| PROxy Network, an initiative of PeriPharm Inc. | Montreal | Quebec | H2Y 1V3 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010051 | Ovarian Neoplasms |
| D000084802 | Caregiver Burden |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| At recruitment |
| Patients and caregivers work productivity loss and activity impairment | Using the Work Productivity and Activity Impairment (WPAI) questionnaire | At recruitment |
| Patient's preference in treatment | Using a questionnaire specifically developed for this study based on a literature search, physician input and patient association input. | At recruitment |
| D000291 |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |
| D013315 | Stress, Psychological |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |